HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Paolo Ascierto Selected Research
Paolo Ascierto Research Topics
Disease
9
Melanoma (Melanoma, Malignant)
11/2021 - 06/2011
5
Neoplasms (Cancer)
01/2019 - 02/2008
3
Disease Progression
10/2020 - 04/2010
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2020 - 06/2011
1
Brain Neoplasms (Brain Tumor)
11/2021
1
Pneumonia (Pneumonitis)
11/2020
1
Cytokine Release Syndrome
11/2020
1
COVID-19
11/2020
1
Residual Neoplasm
12/2018
1
Neoplasm Metastasis (Metastasis)
12/2018
1
Carcinogenesis
03/2013
1
Exanthema (Rash)
06/2011
1
Diarrhea
06/2011
1
Keratoacanthoma
06/2011
1
Fatigue
06/2011
1
Arthralgia (Joint Pain)
06/2011
1
Alopecia (Baldness)
06/2011
1
Nausea
06/2011
1
Non-Muscle Invasive Bladder Neoplasms
04/2010
Drug/Important Bio-Agent (IBA)
2
Immune Checkpoint Inhibitors
IBA
10/2020 - 01/2016
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
11/2021
1
dabrafenib
IBA
11/2021
1
trametinib
IBA
11/2021
1
tocilizumab (atlizumab)
FDA Link
11/2020
1
Interleukin-6 (Interleukin 6)
IBA
11/2020
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
10/2020
1
Biological Products
IBA
01/2019
1
Biomarkers (Surrogate Marker)
IBA
12/2018
1
1-methyl-1-piperidinomethane sulfonate
IBA
02/2016
1
Microphthalmia-Associated Transcription Factor
IBA
02/2016
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
02/2016
1
Vaccines
IBA
01/2016
1
Monoclonal Antibodies
IBA
01/2016
1
Ipilimumab
IBA
10/2013
1
Proteins (Proteins, Gene)
FDA Link
03/2013
1
Interferon alpha-2 (Roferon-A)
FDA Link
10/2012
1
Interferons
IBA
10/2012
1
Proto-Oncogene Proteins B-raf
IBA
06/2011
1
Vemurafenib
IBA
06/2011
1
Dacarbazine (DIC)
FDA Link
Generic
06/2011
1
Gemcitabine
FDA Link
04/2010
1
Antibodies
IBA
02/2008
Therapy/Procedure
5
Therapeutics
10/2020 - 10/2012
5
Immunotherapy
07/2020 - 02/2008
1
Retreatment
10/2020
1
EAP protocol
10/2013
1
Cystectomy
04/2010
1
Biological Therapy
02/2008